Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of injectable THDBH120 in overweight or obese Chinese adults
CTR20244607Phase 2Completed
- Sponsor
- Dongbao Zixing (Hangzhou) Biomedical Co., Ltd.
- Start
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of THDBH120 in obesity, Overweight, sponsored by Dongbao Zixing (Hangzhou) Biomedical Co., Ltd.. Started Dec 2024; status: completed.
02
Drugs
THDBH120
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20244607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244607.